Filtered by Category: Lead Counsel
Pomerantz has been named co-lead counsel in a securities class action against Canopy Growth Corporation concerning alleged material misstatements and omissions related to the company’s financial performance and internal controls.
Read MorePomerantz was recently named Co-Lead Counsel in a shareholder suit against PacWest Bancorp. The suit alleges that PacWest misled investors about the company’s financial situation and the effect that increases in interest rates would have on its liquidity.
Read MorePomerantz was recently appointed co-lead counsel in a securities class action against the pharmaceutical company Apellis. The suit alleges that the company misled investors about the safety of one of its treatments for an eye condition that can lead to blindness.
Read MoreOn January 4, United States Magistrate Judge James R. Cho of the United States District Court for the Eastern District of New York named Pomerantz Lead Counsel in a securities class action against Uruguayan fintech company DLocal. The case alleges that DLocal made misleading statements about its compliance with Argentine financial regulations.
Read MorePomerantz was recently appointed Lead Counsel in a securities class action against medical and commercial manufacturing conglomerate Danaher Corporation. The suit alleges that Danaher misled investors about the company’s financial prospects following the growth it experienced during the COVID-19 pandemic.
Read MorePomerantz has been named Lead Counsel in a securities class action against the pharmaceutical company ImmunityBio. The suit alleges that ImmunityBio failed to disclose serious deficiencies in its manufacturing processes which ultimately led the FDA to reject its application for approval of its premier drug candidate.
Read MorePomerantz recently overcame defendants’ motion to dismiss its securities class action suit against the well-known food storage company Tupperware. The case concerns alleged misstatements about the company’s actions to combat rising costs and dwindling profit margins.
Read MoreLast week, Judge Jacqueline Scott Corley of the United States District Court for the Northern District of California named Pomerantz as sole lead counsel in a securities class action against Hawaiian Electric Industries Inc. The case concerns the utility company’s conduct leading up to the deadly fires that broke out in Maui earlier this year.
Read MoreThe United States District Court for the Eastern District of New York has named Pomerantz Co-Lead Counsel in a securities class action against Peloton Interactive, Inc. The case involves alleged misstatements and omissions from Peloton regarding the safety of its products.
Read MoreOn April 4, 2023, U.S. District Judge Jesse M. Furman, of the Southern District of New York, appointed Pomerantz LLP as Lead Counsel on behalf of Omar Miramontes – the Lead Plaintiff, and the class, in In re Y-mAbs Therapeutics, Inc. Sec. Lig., 23-cv-431 (S.D.N.Y.). This securities class action alleges that Y-mAbs Therapeutics, Inc. misled investors regarding the efficacy of Omburtamab and the regulatory and commercial prospects of the drug. Y-mAbs is a clinical-stage biopharmaceutical company that develops antibody-based therapeutics and medicines for the treatment of cancer. Omburtamab is the Company’s lead product candidate for the treatment of neuroblastoma in the central nervous system or leptomeninges…
Read MoreOn April 3, 2023, U.S. District Judge Brian R. Martinotti, of the District of New Jersey, appointed Pomerantz LLP as Lead Counsel on behalf of Peter Catanese – the Lead Plaintiff, and the class, in In re BioLineRx Sec. Litig, 23-cv-41 (D.N.J.). This securities class action alleges that BioLineRx Ltd. misled investors regarding its ability to finance the development and commercial launch of products in its pipeline. BioLineRx is a pre-commercial-stage biopharmaceutical company focused on oncology. The Company’s lead product candidate is Motixafortide, a stem cell mobilization treatment for patients with multiple myeloma (plasma cell cancer). Allegations against BioLineRx include that: (i) the Company failed to…
Read MoreOn March 21, 2023, U.S. District Judge Vernon S. Broderick, of the Southern District of New York, appointed Pomerantz LLP as Lead Counsel on behalf of the New York City Public Pension Funds – the Lead Plaintiff, and the class, in Choi v. Coupang, Inc., 22-cv-7309 (S.D.N.Y.). This securities class action alleges that Coupang, Inc. misled investors by engaging in improper anticompetitive practices, manipulating the search algorithms, product reviews and pricing in its marketplace platform, and subjecting its workforce to extreme, unsafe, and unhealthy working conditions. Coupang is one of the largest e-commerce companies in Asia, often referred to as the Amazon.com of South Korea. The Company’s Rocket Wow membership subscribers can make direct purchases of goods…
Read MoreOn March 8, 2023, U.S. District Judge Rodolfo A. Ruiz II, of the Southern District of Florida, appointed Pomerantz LLP as Co-Lead Counsel on behalf of its client, who serves as the Co-Lead Plaintiff, and the class, in Vargas v. Citrix Systems, Inc., 22-cv-62327 (S.D. Fla.). This securities action alleges that Citrix Systems, Inc. misled investors about the true value of the Company in order to sell it at an unfairly low price per share. Citrix is a software company that provides users with secure remote access to computer networks through solutions that include servers, applications, desktop virtualization software and cloud computing technologies. Allegations against Citrix include that: (i) the Company’s Board's used false projections to conceal the true value of Citrix; (ii) based on…
Read MoreOn March 7, 2023, U.S. District Judge William H. Orrick, of the Northern District of California, appointed Pomerantz LLP as Lead Counsel on behalf of Mark Kusnier – the Lead Plaintiff, and the class, in Kusnier v. Affirm Holdings, Inc., 22-cv-7770 (N.D. Cal.). This securities class action alleges that Affirm Holdings, Inc. misled investors regarding the risks and benefits of its services to consumers and the Company’s adherence to consumer protection laws. Affirm operates a platform for digital and mobile-first commerce in the U.S. and Canada, including point-of-sale payment solutions for consumers, merchant commerce solutions, and a consumer-focused app. Particularly, Affirm offers a payment service…
Read MoreOn February 3, 2023, U.S. Senior District Judge Marsha J. Pechman, of the Western District of Washington, appointed Pomerantz LLP as Lead Counsel on behalf of Martin Sohovich – the Lead Plaintiff, and the class, in Parekh v. Avalara, Inc., 22-cv-1580 (W.D. Wash.). This securities class action alleges that Avalara, Inc. misled investors regarding the true value of the Company before a shareholder vote to approve its acquisition by Vista Equity Partners Management, LLC for $93.50 per share. Avalara is a SaaS (software as a service) company that provides small and mid-sized businesses with cloud-based solutions for the calculation and management of sales tax and the automation of transaction tax compliance. Allegations against…
Read MoreOn January 31, 2023, U.S. District Judge Deborah K. Chasanow, of the District of Maryland, appointed Pomerantz LLP as Lead Counsel on behalf of Dustin Fanucchi – the Lead Plaintiff, and the class, in Fagen v. Enviva Inc., 22-cv-2844 (D. Md.). This securities class action alleges that Enviva Inc. misled the market regarding its business model, financial performance, and prospects for growth. Enviva is the world’s largest producer of utility-grade wood pellets that are used as a substitute for coal in power generation by industrial customers. Significantly, Enviva touts itself as a “growth-oriented” environmental, social, and governance (“ESG”) company with a “platform to generate stable and growing cash flows.” Allegations…
Read MoreOn January 19, 2023, U.S. District Judge Mark C. Scarsi, of the Central District of California, appointed Pomerantz LLP as Co-Lead Counsel on behalf of its client, William Baker, who serves as the Lead Plaintiff, and the class, in Baker v. Twitter, Inc., 22-cv-6525 (C.D. Cal.). This securities action alleges that Twitter, Inc. misled the market regarding security concerns about its the platform and the effectiveness of its cybersecurity defenses. Twitter operates a global social media platform. In March 2011, Twitter agreed to a settlement with the Federal Trade Commission regarding a complaint that the Company mishandled users’ private information and allowed too many employees to have access to the platform’s central controls. As…
Read MoreOn December 12, 2022, U.S. Magistrate Judge Sarah L. Cave, of the Southern District of New York, appointed Pomerantz LLP as Co-Lead Counsel on behalf of its client, Jamia Fernandes, who serves as the Co-Lead Plaintiff, and the class, in Fernandes v. Centessa Pharmaceuticals PLC, 22-cv-8805 (S.D.N.Y.). This securities action alleges that Centessa Pharmaceuticals plc misled the market regarding the safety and commercial prospects for lixivaptan and ZF874, two of the drugs in its development pipeline. Centessa is a clinical-stage biopharmaceutical company that develops and delivers medicines to patients. The Company’s development pipeline includes lixivaptan, a vasopressin V2…
Read MoreOn December 9, 2022, U.S. Magistrate Judge André M. Espinosa, of the District of New Jersey, appointed Pomerantz LLP as Co-Lead Counsel on behalf of its client, Joshua Mailey, who serves as the Co-Lead Plaintiff, and the class, in In re Humanigen, Inc. Sec. Litig., 22-cv-5258 (D.N.J.). This securities action alleges that Humanigen, Inc. misled the market regarding the regulatory and commercial prospects for lenzilumab – its lead product candidate an antibody treatment for cytokine storm (an auto-immune response triggered by infection that results in the overproduction of inflammatory proteins in the bloodstream). Humanigen is a clinical-stage biopharmaceutical company…
Read MoreOn November 25, 2022, U.S. District Judge Jon S. Tigar of the Northern District of California appointed Pomerantz LLP as Lead Counsel on behalf of Steve Padget – the Lead Plaintiff, and the class, in Kampe v. Volta Inc., 22-cv-2055 (N.D. Cal.). This securities class action alleges that Volta Inc. misled the market regarding the accuracy of its financial reporting and strength of its financial results. Volta owns and operates a network of electric vehicle (EV) charging stations across the United States. The Company was formed as a result of a business combination in August 2021 between Volta Industries, Inc. and Tortoise Acquisition Corp. II, a special purpose acquisition company. Allegations against Volta include that…
Read More